Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder
Swati Dhasmana, Anupam Dhasmana, Acharan S. Narula, et al.
Life Sciences (2021) Vol. 288, pp. 120156-120156
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Recent Advances on the Role of Brain-Derived Neurotrophic Factor (BDNF) in Neurodegenerative Diseases
Khairunnuur Fairuz Azman, Rahimah Zakaria
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6827-6827
Open Access | Times Cited: 125
Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities
Xiaoxue Xu, Bowen Sun, Chuansheng Zhao
Neurobiology of Disease (2023) Vol. 187, pp. 106314-106314
Open Access | Times Cited: 28
Neuroprotective Effects of Olive Oil: A Comprehensive Review of Antioxidant Properties
Marta Gonçalves, Nuno Vale, Paula Silva
Antioxidants (2024) Vol. 13, Iss. 7, pp. 762-762
Open Access | Times Cited: 9
Neuroprotective potential of Moringa oleifera mediated by NF‐kB/Nrf2/HO‐1 signaling pathway: A review
Maroti Mundkar, Anjali Bijalwan, Divya Soni, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 12
Open Access | Times Cited: 29
Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis
Maruša Barbo, Metka Ravnik‐Glavač
Genes (2023) Vol. 14, Iss. 2, pp. 325-325
Open Access | Times Cited: 22
The Key Role of Astrocytes in Amyotrophic Lateral Sclerosis and Their Commitment to Glutamate Excitotoxicity
Francesca Provenzano, Carola Torazza, Tiziana Bonifacino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15430-15430
Open Access | Times Cited: 21
Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis
Hong Du, Chi Zhang, Wenshuo Wu, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 18
ALS patient-derived motor neuron networks exhibit microscale dysfunction and mesoscale compensation rendering them highly vulnerable to perturbation
Vegard Fiskum, Nicolai Winter‐Hjelm, Nicholas Christiansen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in experimental rats
Rakesh Sahu, Sidharth Mehan, Sumit Kumar, et al.
Toxicology Reports (2022) Vol. 9, pp. 977-998
Open Access | Times Cited: 25
VEGF and Neuronal Survival
Paula M. Calvo, Rosendo G. Hernández, Ángel M. Pastor, et al.
The Neuroscientist (2022) Vol. 30, Iss. 1, pp. 71-86
Closed Access | Times Cited: 20
Rising Voltage-Gated Potassium Channel Antibody Level as a Possible Disease Progression Marker for Amyotrophic Lateral Sclerosis: A Case Report
Sophia Salter, Ethan Salter, Anhye Kim, et al.
Cureus (2025)
Open Access
Unraveling the Multifaceted Insights into Amyotrophic Lateral Sclerosis: Genetic Underpinnings, Pathogenesis, and Therapeutic Horizons
Ramaish Sharma, Zuber Khan, Sidharth Mehan, et al.
Mutation Research/Reviews in Mutation Research (2024) Vol. 794, pp. 108518-108518
Closed Access | Times Cited: 3
New perspectives of the role of skeletal muscle derived extracellular vesicles in the pathogenesis of amyotrophic lateral sclerosis: the ‘dying back’ hypothesis
Carolina Sbarigia, Sophie Rome, Luciana Dini, et al.
Journal of Extracellular Biology (2024) Vol. 3, Iss. 11
Open Access | Times Cited: 3
Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy
Eva Bagyinszky, John Hulme, Seong Soo A. An
Cells (2023) Vol. 12, Iss. 15, pp. 1948-1948
Open Access | Times Cited: 7
Role of vascular endothelial growth factor as a critical neurotrophic factor for the survival and physiology of motoneurons
Paula M. Calvo, RosendoG Hernández, RosaR de la Cruz, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 8
Open Access | Times Cited: 12
Microglia Influence Neurofilament Deposition in ALS iPSC-Derived Motor Neurons
Reilly L. Allison, Jacob W. Adelman, Jenica Abrudan, et al.
Genes (2022) Vol. 13, Iss. 2, pp. 241-241
Open Access | Times Cited: 11
Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis
Claudia Albertini, Alessandra Salerno, Silvia Atzeni, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 15, pp. 2252-2260
Open Access | Times Cited: 8
Microstructural Changes in the Corpus Callosum in Neurodegenerative Diseases
Emad Ali Albadawi
Cureus (2024)
Open Access | Times Cited: 1
Nanotechnological advancement for the treatment of neurodegenerative disorders
Garima Rai, Surbhi Sharma, Aditi Singh, et al.
Journal of Dispersion Science and Technology (2024), pp. 1-19
Closed Access | Times Cited: 1
The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis
Ann Logan, Antonio Belli, Valentina Di Pietro, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Aberrantly Expressed Hsa_circ_0060762 and CSE1L as Potential Peripheral Blood Biomarkers for ALS
Metka Ravnik‐Glavač, Massimo Mezzavilla, Ana Dolinar, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1316-1316
Open Access | Times Cited: 3
Boosting Mitochondrial Potential: An Imperative Therapeutic Intervention in Amyotrophic Lateral Sclerosis
Swati Dhasmana, Anupam Dhasmana, Sudhir Kotnala, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 5, pp. 1117-1138
Open Access | Times Cited: 5
Diffusion magnetic resonance imaging-based surrogate marker in amyotrophic lateral sclerosis
Yuya Saito
Exploration of Neuroprotective Therapy (2023), pp. 186-206
Open Access | Times Cited: 2
Neural Stem Cell Therapies: Promising Treatments for Neurodegenerative Diseases
Amir Gholamzad, Hadis Sadeghi, Maryam Azizabadi Farahani, et al.
Neurology Letters (2023) Vol. 2, Iss. 2, pp. 55-68
Open Access | Times Cited: 2
Integrative Profiling of Amyotrophic Lateral Sclerosis Lymphoblasts Identifies Unique Metabolic and Mitochondrial Disease Fingerprints
Teresa Cunha‐Oliveira, Marcelo Carvalho, Vilma A. Sardão, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 6373-6396
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top